FEATURED NEWS
NEWS: ACUITAS DONATES TO BC CANCER FOUNDATION (NOV 2023)
Acuitas President & CEO, Dr. Thomas Madden, was recently interviewed by Techcouver about our donation to BC Cancer Foundation to support liver cancer research. Click to read the article.
NEWS: VERVE THERAPEUTICS ANNOUNCES HUMAN PROOF-OF-CONCEPT DATA FOR VERVE-101 (NOV 2023)
Congratulations to our partner Verve for the newly released positive results from their VERVE-101 heart-1 phase 1b clinical trial. VERVE-101 uses our proprietary best-in-class LNP delivery system. Click for more info.
NEWS: ACUITAS APPOINTS DR. GHANIA CHIKH AS SENIOR DIRECTOR, VACCINE DEVELOPMENT (NOV 2023)
Dr. Ghania Chikh has been appointed Senior Director, Vaccine Development for Acuitas. With decades of experience in drug development, she will oversee the vaccine development program – working with Acuitas’ global partners. Click for more info.